Anti-aging skincare, retinol, peptides, various firmness-marketed actives, genuinely works on certain aspects of visible aging, particularly fine lines and some texture. Sagging specifically often doesn't respond the same way, even to a consistent, well-formulated routine, and understanding why explains a common source of frustration.
What Topical Products Actually Reach
Retinol and most peptides work within the epidermis and upper dermis, skin's surface and near-surface layers. Within that reach, they can genuinely support collagen production, improve texture, and soften fine lines. What they generally can't reach at meaningful concentration is the deeper connective tissue layer beneath the skin, which plays a separate role in how skin sits on the face structurally.
Why Sagging Is Different From Fine Lines
Sagging is largely structural, tied to how skin, underlying fascia, and supportive tissue hold their position and tension over time. As that connective tissue loses elasticity with age, a separate process from surface-level collagen changes, the skin above it loses underlying support. That shows up as sagging or loss of definition, independent of whatever's happening at the surface.
Topical products, working mostly at the surface, don't have meaningful reach into this deeper layer. A well-executed anti-aging routine can visibly improve fine lines and texture while sagging continues largely unaddressed. The two concerns respond to different mechanisms, and topical products only reach one of them.
Why This Matters for Realistic Expectations
If sagging is your primary concern, even a well-chosen topical routine is addressing a different structural layer than the one responsible for it. That doesn't make the products ineffective. It means they're effective for what they can reach, and sagging generally needs an approach that also touches the deeper connective tissue, not skincare working at the surface alone.